Tuberculosis and AIDS Free

Abstract

Summary

Since the mid-1980s, the rate of decline in reported cases of tuberculosis (TB) has reached a plateau or reversed because of a combination of poverty and increased homelessness, immigration and displacement, poorly managed and supplied TB control programmes and, particularly in the developing world, the emergence of human immunodeficiency virus (HIV) infection. TB in HIV-positive patients may present atypically, both clinically and radiologically, with a lower probability of sputum positivity, greater difficulty in diagnosis, and a more rapid clinical deterioration than TB in HIV-seronegative patients. The emergence of multiple-drug-resistant strains of , particularly in patients infected by HIV, carries a high mortality and has been associated with outbreaks in Europe and the USA. Microscopy and culture form the basis of diagnosis, but there is a need for more rapid diagnostic techniques and novel methods of drug susceptibility testing. Prolonged supervised treatment programmes and the development of new chemotherapeutic agents and regimens are essential prerequisites for successful TB therapy in AIDS patients. This review examines the clinical, microbiological and epidemiological issues associated with TB in HIV-infected individuals.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-43-2-85
1995-08-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/43/2/medmicro-43-2-85.html?itemId=/content/journal/jmm/10.1099/00222615-43-2-85&mimeType=html&fmt=ahah

References

  1. Raviglione M. C., Snider D. E., Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995; 273:220–226
    [Google Scholar]
  2. Bloom B. R., Murray C. J. L. Tuberculosis: commentary on areemergent killer. Science 1992; 257:1055–1064
    [Google Scholar]
  3. Murray C. J. L., Styblo K., Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990; 65:6–24
    [Google Scholar]
  4. Jereb J. A., Kelly G. D., Dooley S. W., Cauthen G. M., Snider D. E. Tuberculosis morbidity in the United States: final data, 1990. MMWR CDCSurveillSumm 1991; 40:(SS–3)23–27
    [Google Scholar]
  5. Joly V., Hance A. J., Yeni P. Mycobacterium tuberculosis infections. Curr Opin Infect Dis 1993; 6:171–178
    [Google Scholar]
  6. Styblo K. Epidemiology of tuberculosis. The Hague, Royal Netherlands Tuberculosis Association Selected Papers. vol 24:1991
    [Google Scholar]
  7. Crofton J., Horne N., Miller F. Clinical tuberculosis. London: Macmillan; 1992
    [Google Scholar]
  8. Mitchison D. A. The action of anti-tuberculosis drugs in short-course chemotherapy. Tubercle 1985; 66:219–225
    [Google Scholar]
  9. World Health Organization, Global Programme on AIDS The current global situation of the HIV/AIDS pandemic. Wkly Epidemiol Rec 1994; 69:191–192
    [Google Scholar]
  10. Dolin P. J., Raviglione M. C., Kochi A. Global tuberculosis incidence and mortality during 1990–2000. Bull WHO 1994; 72:213–220
    [Google Scholar]
  11. Grzybowski S. Tuberculosis in the Third World. Thorax 1991; 46:689–691
    [Google Scholar]
  12. Porter J. D. H., McAdam K. P. W. J. Aspects of tuberculosis in Africa. I. Tuberculosis in Africa in the AIDS era—the role of chemoprophylaxis. Trans R Soc Trop Med Hyg 1992; 86:467–469
    [Google Scholar]
  13. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991; 72:1–6
    [Google Scholar]
  14. Styblo K. Tuberculosis control and surveillance. In Fleny D. C., Perry T. L. (eds) Recent advances in respiratory medicine, no. 4 Edinburgh: Churchill Livingstone; 198677–108
    [Google Scholar]
  15. Anderson J. Particular issues for African women. In Johnson M. A., Johnstone F. D. (eds) HIV infection in women Edinburgh: Churchill Livingstone; 1993269–274
    [Google Scholar]
  16. Syabbalo N. C. Pulmonary tuberculosis and acquired immunodeficiency syndrome. Chest 1987; 92:383–384
    [Google Scholar]
  17. Elliott A. M., Luo N., Tembo G. Impact of HIV on tuberculosis in Zambia:a cross sectional study. BMJ 1990; 301:412–415
    [Google Scholar]
  18. De Cock K. M., Soro B., Coulibaly I. M., Lucas S. B. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992; 268:1581–1587
    [Google Scholar]
  19. Chintu C., Bhat G., Luo C. Seroprevalence of human immunodeficiency virus type 1 infection in Zambian children with tuberculosis. Pediatr Infect Dis J 1993; 12:499–504
    [Google Scholar]
  20. Drucker E., Alcabes P., Bosworth W., Sckell B. Childhood tuberculosis in the Bronx, New York. Lancet 1994; 343:1482–1485
    [Google Scholar]
  21. Ellner J. J., Hinman A. R., Dooley S. W. Tuberculosis symposium: emerging problems and promise. J Infect Dis 1993; 168:537–551
    [Google Scholar]
  22. Chaisson R. E., Schecter G. F., Theuer C. P., Rutherford G. W., Echenberg D. F., Hopewell P. C. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis 1987; 136:570–574
    [Google Scholar]
  23. Raviglione M. C., Sudre P., Rieder H. L., Spinaci S., Kochi A. Secular trends of tuberculosis in western Europe. Bull WHO 1993; 71:297–306
    [Google Scholar]
  24. Hubert B., Pelletier A. Les cas declares de tuberculose en France en 1990. Bull Epidemiol Hebd 1991; 48/91:207–208
    [Google Scholar]
  25. Antonucci G., Armignacco O., Girardi E. Tuberculosis and human immunodeficiency virus infection in Italy. Preliminary results from a multicenter study. Chest 1991; 100:586
    [Google Scholar]
  26. Uttley A. H. C., Pozniak A. Resurgence of tuberculosis. J Hosp Infect 1993; 23:249–253
    [Google Scholar]
  27. Medical Research Council, Cardiothoracic Epidemiology Group National survey of notifications in England and Wales in 1988. Thorax 1992; 47:770–775
    [Google Scholar]
  28. Abouya Y. L., Beaumel A., Lucas S. Pneumocystis carinii pneumonia. An uncommon cause of death in African patients with acquired immunodeficiency syndrome. Am Rev Respir Dis 1992; 145:617–620
    [Google Scholar]
  29. Nunn P., Brindle R., Carpenter L. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6 month) mortality. Am Rev Respir Dis 1992; 146:849–854
    [Google Scholar]
  30. Barber T. W., Craven D. E., McCabe W. R. Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. A report of 9 cases and a review of the literature. Medicine 1990; 69:375–383
    [Google Scholar]
  31. Elliott A. M., Halwiindi B., Hayes R. J. The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. J Trop Med Hvg 1993; 96:1–11
    [Google Scholar]
  32. Daley C. L., Small P. M., Schector G. F. An outbreak of tuberculosis with accelerated progression among persons infected with human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992; 326:231–235
    [Google Scholar]
  33. Selwyn P. A., Hartel D., Lewis V. A. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320:545–550
    [Google Scholar]
  34. Brisson-Noel A., Gicquel B., Lecossier D., Levy-Frebault V., Nassif X., Hance A. J. Rapid diagnosis of tuberculosis by amplification of mycobacterial DNA in clinical samples. Lancet 1989; 2:1069–1071
    [Google Scholar]
  35. Alland D., Kalkut G. E., Moss A. R. Transmission of tuberculosis in New-York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330:1710–1716
    [Google Scholar]
  36. Small P. M., Hopewell P. C., Singh S. P. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994; 330:1703–1709
    [Google Scholar]
  37. Das S., Chan S. L., Allen B. W., Mitchison D. A., Lowrie D. B. Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy. Tubercle Lung Dis 1993; 74:47–51
    [Google Scholar]
  38. Godfrev-Fausset P., Wilkins E. G. L., Khoo S., Stoker N. Tuberculosis pericarditis confirmed by DNA amplification. Lancet 1991; 337:176–177
    [Google Scholar]
  39. Kent R. J., Uttley A. H. C., Stoker N. G., Miller R., Pozniak A. L. Transmission of tuberculosis in a British centre for patients infected with HIV. BMJ 1994; 309:639–640
    [Google Scholar]
  40. Hermans P. W. M., Schuitema A. R. J., Van Soolingen D. Specific detection of Mycobacterium tuberculosis complex strains by polymerase chain reaction. J Clin Microbiol 1990; 28:1204–1213
    [Google Scholar]
  41. Hermans P. W. M., van Soolingen D., Dale J. W. Insertion element IS986 from Mycobacterium tuberculosis: a useful tool for diagnosis and epidemiology of tuberculosis. J Clin Microbiol 1990; 28:2051–2058
    [Google Scholar]
  42. Zainuddin Z. F., Dale J. W. Polymorphic repetitive DNA sequences in Mycobacterium tuberculosis detected with a gene probe from a Mycobacterium fortuitum plasmid. J Gen Microbiol 1989; 135:2347–2355
    [Google Scholar]
  43. Drobniewski F., Bruce M., Kambashi B. The use of DNA fingerprinting in the analysis of African Mycobacterium tuberculosis isolates. J Med Microbiol 1994; 40 Suppl 1 Abstract no. 281
    [Google Scholar]
  44. Drobniewski F. A., Kent R. J., Stoker N. G., Uttley A. H. C. Molecular biology in the diagnosis and epidemiology of tuberculosis. J Hosp Infect 1994; 28:249–263
    [Google Scholar]
  45. Dooley S. W., Jarvis W. R., Martone W. J., Snider D. E. Multidrug-resistant tuberculosis. Ann Intern Med 1992; 117:257–259
    [Google Scholar]
  46. Edlin B. R., Tokars J. I., Grieco M. H. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326:1514–1521
    [Google Scholar]
  47. Coronado V. G., Beck-Sague C. M., Hutton M. D. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis 1993; 168:1052–1055
    [Google Scholar]
  48. Small P. M., Shafer R. W., Hopewell P. C. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993; 328:1137–1144
    [Google Scholar]
  49. Centers for Disease Control Nosocomial transmission of multidrug resistant tuberculosis among HIV-infected persons—Florida and New York 1988. 91 MMWR 1991; 40:585–591
    [Google Scholar]
  50. Frieden T. R., Sterling T., Pablos-Mendez A., Kilburn J. O., Cauthen G. M., Dooley S. W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328:521–526
    [Google Scholar]
  51. Fischl M. A., Uttamchandani R. B., Daikos G. L. An outbreak of tuberculosis caused by multiple drug-resistant tubercle bacilli among patients with HIV infection. Am Intern Med 1992; 117:177–183
    [Google Scholar]
  52. Eriki P. P., Okwera A., Aisu T., Morrissey A. B., Ellner J. J., Daniel T. M. The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda. Am Rev Respir Dis 1991; 143:185–187
    [Google Scholar]
  53. Small P. M., Schecter G. F., Goodman P. C., Sande M. A., Chaisson R. E., Hopewell P. C. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 1991; 324:289–294
    [Google Scholar]
  54. Brindle R. J. Aspects of tuberculosis in Africa. 2. The value of microbiology in the management of tuberculosis in Nairobi, Kenya. Trans R Soc Trop Med Hyg 1992; 86:470–471
    [Google Scholar]
  55. Soriano E., Mallolas J., Gatell J. M. Characteristics of tuberculosis in HIV-infected patients: a case-control study. AIDS 1988; 2:429–432
    [Google Scholar]
  56. Centers for Disease Control and Prevention Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the advisory council for the elimination of tuberculosis. MMWR 1993; 42:1–8
    [Google Scholar]
  57. Iseman M. D., Madsen L. A. Drug-resistant tuberculosis. Clin Chest Med 1989; 10:341–353
    [Google Scholar]
  58. Hawken M., Nunn P., Gathua S. Increased recurrence of tuberculosis in HIV1-infected patients in Kenya. Lancet 1993; 342:332–337
    [Google Scholar]
  59. Mahmoudi A., Iseman M. D. Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. JAMA 1993; 270:65–68
    [Google Scholar]
  60. Goble M., Iseman M. D., Madsen L. A., Waite D., Ackerson L., Horsburgh C. R. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993; 328:527–532
    [Google Scholar]
  61. Shafer R. W., Chirgwin K. D., Glatt A. E., Dahdouh M. A., Landesman S. H., Suster B. HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS. AIDS 1991; 5:399–405
    [Google Scholar]
  62. Long R., Scalcini M., Manfreda J. Impact of human immunodeficiency virus type 1 on tuberculosis in rural Haiti. Am Rev Respir Dis 1991; 143:69–73
    [Google Scholar]
  63. Warburton A. R. E., Jenkins P. A., Waight P. A., Watson J. M. Drug resistance in initial isolates of Mycobacterium tuberculosis in England and Wales, 1982–1991. Commun Dis Rep CDR Review 1993; 3:R175–R179
    [Google Scholar]
  64. Nisar M., Narula M., Beeching N., Davies P. D. O. HIV-related tuberculosis in England and Wales. Tuberc Lung Dis 1992; 73:200–202
    [Google Scholar]
  65. Di Perri G., Danzi M. C., de Checchi G. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 1989; 2:1502–1504
    [Google Scholar]
  66. Beck-Sague C., Dooley S. W., Hutton M. D. Hospital outbreak of multi-drug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA 1992; 268:1280–1286
    [Google Scholar]
  67. Pearson M. L., Jereb J. A., Frieden T. R. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers. Ann Intern Med 1992; 117:191–196
    [Google Scholar]
  68. Nunn P., Mungai M., Nyamwaya J. The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. Tuberc Lung Dis 1994; 75:25–32
    [Google Scholar]
  69. Dooley S. W., Castro K. G., Hutton M. D., Mullan R. J., Polder J. A., Snider D. E. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR 1990; 39:1–29
    [Google Scholar]
  70. Department of Health and Human Services Draft guidelines for preventing the transmission of tuberculosis in healthcare facilities. Federal Register 1993; 58:52810–52854
    [Google Scholar]
  71. Nettleman M. D., Frederickson M., Good N. L., Hunter S. A. Tuberculosis control strategies: the cost of particulate respirators. Ann Intern Med 1994; 121:37–40
    [Google Scholar]
  72. Adal K. A., Anglim A. M., Palumbo C. L., Titus M. G., Coyner B. J., Farr B. M. The use of high-efficiency particulate air-filter respirators to protect hospital workers from tuberculosis. A cost-effectiveness analysis. N Engl J Med 1994; 331:169–173
    [Google Scholar]
  73. Joint Tuberculosis Committee of the British Thoracic Society Control and prevention of tuberculosis in the United Kingdom: Code of practice 1994. Thorax 1994; 49:1193–1200
    [Google Scholar]
  74. Anon. Control of tuberculosis transmission in health care settings A joint statement of the International Union Against Tuberculosis and Lung Disease (IUATLD) and the Tuberculosis Programme of the World Health Organization (WHO). Tuberc Lung Dis 1994; 75:94–95
    [Google Scholar]
  75. Anon. Tuberculosis preventive therapy in HIV-infected individuals A joint statement of the International Union Against Tuberculosis and Lung Disease (IUATLD) and the Global Programme on AIDS and the Tuberculosis Programme of the World Health Organization (WHO). Tuberc Lung Dis 1994; 75:96–98
    [Google Scholar]
  76. Menzies D., Fanning A., Yuan L., Fitzgerald M. Current concepts: tuberculosis among health care workers. NEngl J Med 1995; 332:92–98
    [Google Scholar]
  77. Jacobs W. R., Barletta R. G., Udani R. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 1993; 260:819–822
    [Google Scholar]
  78. Zhang Y., Young D. Molecular genetics of drug resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 1994; 34:313–319
    [Google Scholar]
  79. Telenti A., Imboden P., Marchesi F. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341:647–650
    [Google Scholar]
  80. Heym B., Honore N., Truffot-Pernot C. Implications of multidrug-resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 1994; 344:293–298
    [Google Scholar]
  81. Martin C., Timm J., Rauzier J., Gomez-Lus R., Davies J., Gicquel B. Transposition of an antibiotic resistance element in mycobacteria. Nature 1990; 345:739–743
    [Google Scholar]
  82. Benson C. A. Mycobacterium tuberculosis and Mycobacterium avium complex disease in patients with HIV infection. Curr Opin Infect Dis 1994; 7:95–107
    [Google Scholar]
  83. Wallace R. J. Current therapy of mycobacterial infections. Curr Opin Infect Dis 1993; 6:758–763
    [Google Scholar]
  84. Houston S., Fanning A. Current and potential treatment of tuberculosis. Drugs 1994; 48:689–708
    [Google Scholar]
  85. Mukadi Y., Perriens J. H., St Louis M. E. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet 1993; 342:143–146
    [Google Scholar]
  86. Lucas S., Nelson A. M. Pathogenesis of tuberculosis in Human Immunodeficiency Virus-infected people. In Bloom B. (ed) Tuberculosis, pathogenesis, protection and control Washington DC: American Society for Microbiology; 1994503–513
    [Google Scholar]
  87. Bloom B. (ed) Tuberculosis: pathogenesis, protection and control Washington DC: American Society for Microbiology; 1994
    [Google Scholar]
  88. Orme I. M., Andersen P., Boom W. H. T cell response to Mycobacterium tuberculosis. J Infect Dis 1993; 167:1481–1497
    [Google Scholar]
  89. Ottenhoff T. H. M., Ab B. K., Van Embden J. D. A., Thole J. E. R., Kiessling R. The recombinant 65-kDa heat shock protein of Mycobacterium bovis bacillus Calmette-guerin M tuberculosis is a target molecule of CD4 + cytotoxic T lymphocytes that lyse human monocytes. J Exp Med 1987; 168:1947–1952
    [Google Scholar]
  90. Boom W. H., Wallis R. S., Chervenak K. A. Human Mycobacterium tuberculosis reactive CD4 + T cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes. Infect Immun 1991; 59:2737–2743
    [Google Scholar]
  91. Forte M., Maartens G., Rahelu M. Cytolytic T-cell activity against mycobacterial antigens in HIV. AIDS 1992; 6:407–411
    [Google Scholar]
  92. Clerici M., Shearer G. M. A TH1-TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14:107–111
    [Google Scholar]
  93. Toossi Z., Sierra-Madero J. G., Blinkhorn R. A., Mettler M. A., Rich E. A. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J Exp Med 1993; 117:1511–1516
    [Google Scholar]
  94. Wallis R. S., Vjecha M., Amir-Tahmasseb M. Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis. J Infect Dis 1993; 167:43–48
    [Google Scholar]
  95. Shattock R. J., Friedland J. S., Griffin G. E. Modulation of HIV transcription in and release from human monocytic cells following phagocytosis of Mycobacterium tuberculosis. Res Virol 1993; 144:7–12
    [Google Scholar]
  96. Matsuyama T., Kobayashi N., Yamamoto N. Cytokines and HIV infection: is AIDS a tumour necrosis factor disease?. AIDS 1991; 5:1405–1417
    [Google Scholar]
  97. Pape J. W., Jean S. S., Ho J. L., Hafner A., Johnson W. D. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342:268–272
    [Google Scholar]
  98. Wadhawan D., Mira S., Mwansa N., Perine P. Preventive tuberculosis chemotherapy with isoniazid among persons infected with HIV. Abstracts of the 8th International Conference on AIDS, Amsterdam, July 1992
    [Google Scholar]
  99. Heymann S. J. Modelling the efficacy of prophylactic and curative therapies for preventing the spread of tuberculosis in Africa. Trans R Soc Trop Med Hyg 1993; 87:406–411
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-43-2-85
Loading

Most cited Most Cited RSS feed